BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 35156343)

  • 21. Secretory carcinoma of breast: A diagnostic dilemma.
    Shukla A; Arshad F; Naseem I
    Indian J Pathol Microbiol; 2020 Feb; 63(Supplement):S143-S145. PubMed ID: 32108648
    [No Abstract]   [Full Text] [Related]  

  • 22. Secretory Carcinoma Breast - The Characteristic Cytological Features in Diagnosis of This Rare Carcinoma.
    Gupta S; Gupta P
    J Cytol; 2020; 37(1):63-65. PubMed ID: 31942102
    [No Abstract]   [Full Text] [Related]  

  • 23. TRK Fusions Are Enriched in Cancers with Uncommon Histologies and the Absence of Canonical Driver Mutations.
    Rosen EY; Goldman DA; Hechtman JF; Benayed R; Schram AM; Cocco E; Shifman S; Gong Y; Kundra R; Solomon JP; Bardelli A; Scaltriti M; Drilon A; Iasonos A; Taylor BS; Hyman DM
    Clin Cancer Res; 2020 Apr; 26(7):1624-1632. PubMed ID: 31871300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast.
    Harrison BT; Fowler E; Krings G; Chen YY; Bean GR; Vincent-Salomon A; Fuhrmann L; Barnick SE; Chen B; Hosfield EM; Hornick JL; Schnitt SJ
    Am J Surg Pathol; 2019 Dec; 43(12):1693-1700. PubMed ID: 31498178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma.
    Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
    Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma.
    Li L; Wu N; Li F; Li L; Wei L; Liu J
    Cancer Biol Med; 2019 Feb; 16(1):139-146. PubMed ID: 31119054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.
    Hoda RS; Brogi E; Pareja F; Nanjangud G; Murray MP; Weigelt B; Reis-Filho JS; Wen HY
    Histopathology; 2019 Aug; 75(2):213-224. PubMed ID: 31012486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular characterization of cancers with NTRK gene fusions.
    Gatalica Z; Xiu J; Swensen J; Vranic S
    Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful Targeted Therapy of Refractory Pediatric
    Shukla N; Roberts SS; Baki MO; Mushtaq Q; Goss PE; Park BH; Gundem G; Tian K; Geiger H; Redfield K; Behr G; Benayed R; Zehir A; Hechtman JF; Darnell RB; Papaemmanuil E; Ladanyi M; Ku N; Kung AL; Baselga J; Drilon A; Hyman DM
    JCO Precis Oncol; 2017; 2017():. PubMed ID: 29623306
    [No Abstract]   [Full Text] [Related]  

  • 30. Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.
    Horowitz DP; Sharma CS; Connolly E; Gidea-Addeo D; Deutsch I
    Breast; 2012 Jun; 21(3):350-3. PubMed ID: 22494666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytodiagnosis of secretory carcinoma of the breast.
    Shanthi V; Rama Krishna BA; Rao NM; Sujatha C
    J Cytol; 2012 Jan; 29(1):63-5. PubMed ID: 22438622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature.
    Li D; Xiao X; Yang W; Shui R; Tu X; Lu H; Shi D
    Mod Pathol; 2012 Apr; 25(4):567-75. PubMed ID: 22157932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytodiagnosis of secretory carcinoma of the breast: a report on two cases.
    Jena M; Shariff S
    Diagn Cytopathol; 2010 Dec; 38(12):921-4. PubMed ID: 21104739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity.
    Skálová A; Vanecek T; Sima R; Laco J; Weinreb I; Perez-Ordonez B; Starek I; Geierova M; Simpson RH; Passador-Santos F; Ryska A; Leivo I; Kinkor Z; Michal M
    Am J Surg Pathol; 2010 May; 34(5):599-608. PubMed ID: 20410810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rare case of secretory breast carcinoma in an elderly woman: correlation of aspiration cytology and histology.
    Mardi K; Sharma J
    Indian J Pathol Microbiol; 2007 Oct; 50(4):865-7. PubMed ID: 18306591
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretory carcinoma of the breast diagnosed by fine needle aspiration.
    Oh YH; Jang KS; Song YS; Paik SS; Park YW; Chon SH
    Acta Cytol; 2005; 49(3):343-4. PubMed ID: 15966301
    [No Abstract]   [Full Text] [Related]  

  • 37. Secretory carcinoma of the male breast: correlation of aspiration cytology and pathology.
    Alenda C; Aranda FI; Seguí FJ; Laforga J
    Diagn Cytopathol; 2005 Jan; 32(1):47-50. PubMed ID: 15584046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretory carcinoma of the breast with a cystically dilated intraductal component: report of a case.
    Izumi J; Komaki K; Hirokawa M; Masuda E; Monden Y
    Surg Today; 2003; 33(2):110-3. PubMed ID: 12616371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma.
    Tognon C; Knezevich SR; Huntsman D; Roskelley CD; Melnyk N; Mathers JA; Becker L; Carneiro F; MacPherson N; Horsman D; Poremba C; Sorensen PH
    Cancer Cell; 2002 Nov; 2(5):367-76. PubMed ID: 12450792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine needle aspiration cytodiagnosis of secretory carcinoma of the breast.
    Gupta RK; Kenwright D; Naran S; Lallu S; Fauck R
    Cytopathology; 2000 Dec; 11(6):496-502. PubMed ID: 11194081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.